12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Merrimack, Cancer Treatment Centers of America deal

Merrimack received non-exclusive access to the centers' archived and prospectively collected tumor biopsies. Merrimack will analyze the samples using its Network Biology approach to...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >